Pharmaceuticals in Singapore

Pharmaceuticals in Singapore

Summary

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Singaporean pharmaceuticals market had total revenues of $940.6m in 2019, representing a compound annual growth rate (CAGR) of 2% between 2015 and 2019.
  • The Singaporean healthcare is the best in the world in terms of both efficiency and health outcome results. Singapore has a record of providing a world-class business environment and skilled talent pool to companies.
  • The Singapore government has invested aggressively in its biomedical industry over the last few years.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the Singapore pharmaceuticals market by value in 2019?
  • What will be the size of the Singapore pharmaceuticals market in 2024?
  • What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Singapore's pharmaceuticals market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What trends have impacted the market?
7.6. Are there any threats towards leading players?
8 Company Profiles
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. Astellas Pharma Inc.
8.4. GlaxoSmithKline Plc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Singapore pharmaceuticals market share: % share, by value, 2019
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Annual Financial Ratios (Continued)
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: Annual Financial Ratios
Table 12: Pfizer Inc.: Key Employees
Table 13: Pfizer Inc.: Key Employees Continued
Table 14: Astellas Pharma Inc.: key facts
Table 15: Astellas Pharma Inc.: Annual Financial Ratios
Table 16: Astellas Pharma Inc.: Key Employees
Table 17: Astellas Pharma Inc.: Key Employees Continued
Table 18: GlaxoSmithKline Plc: key facts
Table 19: GlaxoSmithKline Plc: Annual Financial Ratios
Table 20: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 21: GlaxoSmithKline Plc: Key Employees
Table 22: GlaxoSmithKline Plc: Key Employees Continued
Table 23: Singapore size of population (million), 2015-19
Table 24: Singapore gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Singapore gdp (current prices, $ billion), 2015-19
Table 26: Singapore inflation, 2015-19
Table 27: Singapore consumer price index (absolute), 2015-19
Table 28: Singapore exchange rate, 2015-19
List of Figures
Figure 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2019
Figure 10: Singapore pharmaceuticals market share: % share, by value, 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook